Macrocyclic compounds and uses thereof
AssigneeTheseus Pharmaceuticals, Inc.
InventorsWei-Sheng Huang, William C. SHAKESPEARE, Charles J. EYERMANN, David C. DALGARNO
Life of this patent
Estimating the term…
Abstract
Described herein are macrocyclic compounds of Formula (I), which can inhibit kinases such as EGFR, including mutant forms such as T790M EGFR mutants. Also described herein are pharmaceutical compositions comprising a compound of Formula (I), or any pharmaceutically acceptable form thereof, processes for their preparation, and use in therapy for the prevention or treatment of cancer. In particular, compounds described herein can be effective for treating EGFR-driven cancers including non-small cell lung cancer (NSCLC).
Claims98
A compound of Formula I:
- or a pharmaceutically acceptable salt thereof,
- wherein:
- A is C6-10 arylene, 5-12-membered heteroarylene, or 5-12-membered heterocycloalkylene;
- X1 is N or CRX;
- X2 is N or CRX;
- X3 is N or CRX;
- X4 is N or CRX;
- X6 is N or CRX′;
- X7 is N or CRX′;
- represents an optional double bond between X7 and X4 or X4 and X6, wherein one and only one double bond is present;
- X5 is a covalent bond, CH2, O, NR4, C(O)NR4, or NR4C(O);
- L1 is a covalent bond or C(R5)2, and L2 is C1-4 alkylene, or L1 and L2 combine to form a C3-6 cycloalkyl or a 4- to 6-membered heterocycloalkyl;
- R1 is halogen, C1-6 alkyl, C3-7 cycloalkyl, C6-10 aryl, 5- to 10-membered heteroaryl, 3- to 10-membered heterocycloalkyl, CN, NR6R7, NR6C(O)R7, NR6C(O)NH2, OR8, or C(O)NR6R7;
- R2 is absent, H, C1-6 alkyl, halogen, CN, or C1-6 alkoxy;
- each R3, when present, is independently OH, CN, halogen, C1-6 alkyl, or C1-6 alkoxy;
- n is 0, 1, or 2;
- each RX is independently H, ORX1, CN, halogen, or C1-6 alkyl, wherein RX1 is H or C1-6 alkyl;
- each RX′ is independently H, ORX1, CN, halogen, or C1-6 alkyl, wherein RX1 is H or C1-6 alkyl, or RX′ is absent if the carbon to which it is attached is part of a double bond;
- each R4 and R5 is independently H or C1-6 alkyl;
- each R6 and R7 is independently H, C1-6 alkyl, C3-7 cycloalkyl, or 3- to 10-membered heterocycloalkyl;
- or R6 and R7 together with the nitrogen atom to which they are attached form a 3- to 8-membered heterocycloalkyl ring;
- and
- R8 is independently H, C1-6 alkyl, or 4- to 6-membered heterocycloalkyl.
Dependencies are inferred from the claim text.